FBT Holdings — First Trust NYSE Arca Biotechnology Index Fund
Data updated: 2026-08-21
FBT holds 32 securities. The top 10 make up 43.2% of net assets, led by Corcept Therapeutics Inc.com (5.60%) and Neogenomics Inc.com New (5.12%). Health Care (94.8%) and Industrials (5.1%) are the largest sectors, and 85.0% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 100.06% of net asset value (99.99% of total assets; remainder is cash and receivables). As of June 30, 2026 · N-PORT.
FBT Portfolio Holdings
32 holdings of First Trust NYSE Arca Biotechnology Index Fund by percentage of net assets, from the fund's SEC N-PORT filing as of June 30, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Corcept Therapeutics Inc.com | CORT | Health Care | 5.60% | $157.46M |
| Neogenomics Inc.com New | NEO | Industrials | 5.12% | $144.00M |
| Veracyte Inc.com | VCYT | Health Care | 5.10% | $143.37M |
| Bruker Corp.com | BRKR | Health Care | 4.32% | $121.51M |
| Alkermes PLC Shs | ALKS | Health Care | 4.24% | $119.20M |
| Illumina Inc.com | ILMN | Health Care | 3.92% | $110.35M |
| Krystal Biotech Inc.com | KRYS | Health Care | 3.87% | $108.91M |
| Natera Inc.com | NTRA | Health Care | 3.79% | $106.73M |
| Axsome Therapeutics Inc.com | AXSM | Health Care | 3.71% | $104.30M |
| Neurocrine Biosciences Inc.com | NBIX | Health Care | 3.53% | $99.24M |
| Bio-Techne Corp.com | TECH | Health Care | 3.43% | $96.54M |
| Arrowhead Pharmaceuticals Inc.com | ARWR | Health Care | 3.38% | $94.97M |
| Biogen Inc.com | BIIB | Health Care | 3.37% | $94.80M |
| Exelixis Inc.com | EXEL | Health Care | 3.32% | $93.28M |
| Incyte Corp.com | INCY | Health Care | 3.18% | $89.56M |
| Argenx SE Sponsored ADR | ARGX | Health Care | 3.13% | $88.06M |
| Halozyme Therapeutics Inc.com | HALO | Health Care | 3.11% | $87.59M |
| Vertex Pharmaceuticals Inc.com | VRTX | Health Care | 3.07% | $86.42M |
| Repligen Corp.com | RGEN | Health Care | 3.07% | $86.22M |
| Biomarin Pharmaceutical Inc.com | BMRN | Health Care | 2.83% | $79.64M |
| Amgen Inc.com | AMGN | Health Care | 2.78% | $78.30M |
| Biontech SE Sponsored ADS | BNTX | Health Care | 2.63% | $73.95M |
| Genmab A/s Sponsored ADS | GMAB | Health Care | 2.62% | $73.80M |
| United Therapeutics Corp.com | UTHR | Health Care | 2.56% | $71.93M |
| Alnylam Pharmaceuticals Inc.com | ALNY | Health Care | 2.52% | $70.92M |
| Beone Medicines Ltd. Sponsored ADS | ONC | Health Care | 2.48% | $69.84M |
| Gilead Sciences Inc.com | GILD | Health Care | 2.45% | $68.97M |
| Adma Biologics Inc.com | ADMA | Health Care | 2.33% | $65.48M |
| Sarepta Therapeutics Inc.com | SRPT | Health Care | 2.29% | $64.39M |
| Regeneron Pharmaceuticals Inc.com | REGN | Health Care | 2.25% | $63.20M |
| Dreyfus Government Cash Management Funds Sh Ben Int | MISXX | Funds & ETFs | 0.05% | $1.53M |
| Daiwa Capital Markets America, Inc. | — | Unknown | 0.00% | $4.69K |
FBT Sector Allocation
First Trust NYSE Arca Biotechnology Index Fund holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 94.8% | 29 |
| Industrials | 5.1% | 1 |
| Funds & ETFs | 0.1% | 1 |
| Unknown | 0.0% | 1 |
FBT Country Allocation
Where First Trust NYSE Arca Biotechnology Index Fund's holdings are domiciled, by percentage of net assets (largest 6).
| Country | % of net assets |
|---|---|
| United States | 85.0% |
| Ireland | 4.2% |
| Netherlands | 3.1% |
| Germany | 2.6% |
| Denmark | 2.6% |
| Switzerland | 2.5% |
FBT Portfolio Allocation
Asset-class allocation of First Trust NYSE Arca Biotechnology Index Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 100.0% |
| Cash & Equivalents | 0.1% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.